Moderna Inc (NASDAQ:MRNA)
| 156.11 BATS BZX Real-Time Price As of 1:14pm ET |  -4.03 / -2.52%Today’s Change | 33.72 Today|||52-Week Range 189.26 | +49.43% Year-to-Date |
Latest MRNA News | Press Releases
Today’s Trading
| Previous close | 160.14 |
| Today’s open | 159.00 |
| Day’s range | 155.24 - 163.57 |
| Volume | 237,704 |
| Average volume (3 months) | 15,570,693 |
| Market cap | $56.4B |
Data as of 1:14pm ET, 04/15/2021
Growth & Valuation
| Earnings growth (last year) | -26.08% |
| Earnings growth (this year) | +1,257.59% |
| Earnings growth (next 5 years) | +33.60% |
| Revenue growth (last year) | +1,234.34% |
| P/E ratio | NM |
| Price/Sales | 49.59 |
| Price/Book | 21.94 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ILMNIllumina Inc | +2.91 | +0.73% |
| GILDGilead Sciences | +0.48 | +0.73% |
| BIIBBiogen | +5.24 | +1.97% |
| EXASExact Sciences Corp | +2.89 | +2.27% |
Data as of 1:15pm ET, 04/15/2021
Financials
| Next reporting date | May 13, 2021 |
| EPS forecast (this quarter) | $2.73 |
| Annual revenue (last year) | $803.4M |
| Annual profit (last year) | -$747.1M |
| Net profit margin | -92.99% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
